BusinessCloud is counting down the technology which could save your life this week and next.

Eva Diagnostics’ aim is to revolutionise blood tests so they can be analysed without a hospital laboratory.

Based in London, the technology was originally developed at Imperial College London in 2013 and the company began to take shape a year later when co-founders Toby Basey-Fisher, Millie Clive-Smith and Rob Balfour won the OneStart Biotech competition.

It was Basey-Fisher who first discovered a method to analyse blood samples with just a single drop of blood from a finger prick.

All of Eva’s technology is securely connected to the cloud so patients and medical staff can stay connected outside of a hospital environment.

The company’s first product AnemiPoint can be used to diagnose and manage anaemia.

COO Millie Clive-Smith: “Anaemia causes exhaustion, impaired cognitive function, stunts growth and contributes to up to 40 per cent of deaths in childbirth.

“If it can be diagnosed, anaemia is often easily cured. AnemiPoint addresses the need for an affordable, accessible anaemia diagnostic.”

The Eva Diagnostics team

The Eva Diagnostics team

AnemiPoint is to be launched at the beginning of 2017 but has undergone a number of user trials with NHS trust hospitals and healthcare practices in East Africa.

Although their first product has not yet gone to market, Eva is currently working on its next innovation.

This is named HemiStat, a connected homecare monitoring system for patients receiving chemotherapy.

Blood counts are a vital way of analysing a patient’s response to chemotherapy but currently they must travel to a clinic to have this measured.

“Around five per cent of patients develop a serious infection due to low white blood cell counts,” explains Clive-Smith.

“Early detection of infection leads to faster hospital referral and improved recovery rates.

“HemiStat home monitoring may enable earlier detection of infection.”

We reported on Monday how Skin Analytics is a tool which aims to improve the survival rate for melanoma skin cancer by providing users with a low-cost way to identify moles which could be cancerous.

On Tuesday we brought you Florence, a telecom-based tech is looking to reduce hospital admissions and keep people in their homes for longer.

And on Wednesday we featured Dublin-based start-up Beats Medical, which helps to improve the lives of those with Parkinson’s disease.

BELOW: Flick through edition 1 of BusinessCloud's interactive digital magazine

BusinessCloud digital edition